Growth factors and their peptide mimetics for treatment of traumatic brain injury ScienceDirect The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Pathway based network medicine identifies novel natural products for Alzheimer's disease Alzheimer's Research & Therapy Springer Nature Link Growth factors and their peptide mimetics for treatment of traumatic brain injury ScienceDirect